T1	Participants 14 62	type 2 (non-insulin-dependent) diabetes mellitus
T2	Participants 234 360	41 subjects with early-stage Type 2 (non-insulin-dependent) diabetes mellitus and 181 subjects with impaired glucose tolerance
